¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cortical layer of ovary"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • buffy layer
    ¿¬Ãþ
  • circular layer
    µ¹¸²Ãþ
  • clear layer
    Åõ¸íÃþ
  • compact layer
    Ä¡¹ÐÃþ
  • cone cell layer
    ¿ø»Ô¼¼Æ÷Ãþ, ¿øÃß¼¼Æ÷Ãþ
  • cuticular layer
    ²®ÁúÃþ
  • cavernous layer
    ÇØ¸éÃþ
  • cambium layer
    Çü¼ºÃþ
  • chondrogenic layer
    ¿¬°ñ¹ß»ýÃþ
  • choriocapillary layer
    ¸Æ¶ô¸·¸ð¼¼Ç÷°üÃþ
  • external pyramidal layer
    ¹Ù±ùÇǶó¹Ìµå¼¼Æ÷Ãþ, ¿ÜÃøÃßü¼¼Æ÷Ãþ
  • embryonic layer
    ¹è¾ÆÃþ
  • ependymal layer
    ³ú½Ç¸·Ãþ
  • feeder layer
    ¿µ¾ç¼¼Æ÷Ãþ
  • fibrous layer
    ¼¶À¯ÆÇ, ¼¶À¯Ãþ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cortical sensory defect
    °ÑÁú°¨°¢°á¼Õ
  • cortical stromal fibrosis
    °ÑÁú¹ÙÅÁÁú¼¶À¯Áõ, ÇÇÁú±âÁú¼¶À¯Áõ
  • infantile cortical hyperostosis
    ¿µ¾Æ°ÑÁú»À°ú´ÙÁõ
  • renal cortical necrosis
    ÄáÆÏ°ÑÁú±«»ç
  • subperiosteal cortical thickening
    »À¸·¹Ø°ÑÁúºñ´ë, °ñ¸·ÇϰñÇÇÁúºñ´ë
  • agar layer method
    ¿ì¹«ÁßÃþ¹ý
  • basal layer
    ¹Ù´ÚÃþ
  • buffy layer
    ¿¬Ãþ
  • cavernous layer
    ÇØ¸éÃþ
  • chondrogenic layer
    ¿¬°ñ¹ß»ýÃþ
  • choriocapillary layer
    ¸Æ¶ô¸·¸ð¼¼Ç÷°üÃþ
  • circular layer
    µ¹¸²Ãþ
  • clear layer
    Åõ¸íÃþ
  • compact layer
    Ä¡¹ÐÃþ
  • cone cell layer
    ¿ø»Ô¼¼Æ÷Ãþ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Huxleys layer
    Çä½½¸®Ãþ
  • Langhans layer
    ¶û±×ÇѽºÃþ.
  • Malpighian layer
    ¸»ÇDZâÃþ
  • Nitabuchs layer
    ´ÏŸºÎÈåÃæ.
  • Sattlers layer
    ÀÚÆ²·¯Ãþ
  • adipose layer
    Áö¹æÃþ(ò·Û¸öµ)
  • adipose layer
    Áö¹æÃþ
  • agar layer method
    ÇÑõÁßÃþ¹ý(¡­ñìöµÛö).
  • anterior layer
    ¾ÕÃþ
  • arrangement of germinal layer
    Á¾ÀÚÃþ¹è¿­
  • functional layer
    ±â´ÉÃþ(ѦÒööµ).
  • functional layer of endometrium
    ÀڱüӸ·±â´ÉÃþ
  • fusiform layer
    ¹æÃß¼¼Æ÷Ãþ
  • ganglion cell layer
    ½Å°æÀý¼¼Æ÷Ãþ(¡­öµ).
  • ganglion cell layer
    ½Å°æÀý¼¼Æ÷Ãþ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • polycystic ovary
    ´Ù³¶³­¼Ò(¡­Õ°áµ).
  • polycystic ovary
    ´Ù³¶³­¼Ò(ÒýÒ¥Õ°áµ)
  • proper ligament of ovary ³ª ligamentum ovarii proprium
    °íÀ¯³­¼ÒÀδë, °íÀ¯³­¼Ò»è(ͳêóÕ°áµßã).
  • resistant ovary syndrome
    ¹«¹ÝÀÀ ³­¼Ò ÁõÈıº
  • stroma of ovary
    ³­¼Ò¹ÙÅÁÁú
  • stroma of ovary
    ³­¼Ò¹öÆÀÁú
  • supernumerary ovary
    ´Ù³­¼Ò(Áõ),°úÀ׳­¼Ò(¡­Õ°áµ) .
  • supernumerary ovary
    °úÀ׳­¼Ò(¡­Õ°áµ)
  • suspensory ligament of ovary
    ³­¼Ò°ÉÀÌÀδë
  • tunica albuginea of ovary
    ³­¼Ò¹é»ö¸·
  • adrenal cortical hormone =adrenocortical hormone
    ºÎ½ÅÇÇÁúÈ£¸£¸ó
  • adrenal cortical insufficiency
    ºÎ½ÅÇÇÁú(±â´É)ºÎÀü(Áõ).
  • cortical alexia
    ÇÇÁú(¼º)(ù«òõàõ)ÀбâºÒ´É(Áõ)(ÝÕÒöñø).
  • cortical alexia
    ÇÇÁú(¼º)½Çµ¶(Áõ)(¡­ã÷Ôæñø).
  • cortical amaurosis
    ÇÇÁú¸Í(¡­Øî).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Spinous layer
    °¡½ÃÃþ
    [¿¾ ¿ë¾î] À¯±ØÃþ
  • Marginal layer
    °¡ÀåÀÚ¸®Ãþ
    [¿¾ ¿ë¾î] º¯¿¬Ãþ
  • Horny layer
    °¢ÁúÃþ
    [¿¾ ¿ë¾î] °¢ÁúÃþ
  • Photosensory layer
    °¨°¢Ãþ
    [¿¾ ¿ë¾î] °¨°¢Ãþ
  • Visceral layer
    °íȯÂÊÆÇ
    [¿¾ ¿ë¾î] ÀåÃøÆÇ
  • Granular layer
    °ú¸³Ãþ
    [¿¾ ¿ë¾î] °ú¸³Ãþ
  • Reticular layer
    ±×¹°Ãþ
    [¿¾ ¿ë¾î] ±×¹°Ãþ
  • Reticular layer
    ±×¹°Ãþ
    [¿¾ ¿ë¾î] ¸Á»óÃþ
  • Myoid cell layer
    ±ÙÀ°¼¶À¯¸ð¼¼Æ÷Ãþ
    [¿¾ ¿ë¾î] ±Ù¼¶À¯¾Æ¼¼Æ÷Ãþ
  • Musculocartilaginous layer
    ±ÙÀ°¿¬°ñÃþ
    [¿¾ ¿ë¾î] ±Ù¿¬°ñÃþ
  • Muscle layer
    ±ÙÀ°Ãþ
    [¿¾ ¿ë¾î] ±ÙÃþ
  • Muscular layer
    ±ÙÀ°Ãþ
    [¿¾ ¿ë¾î] ±ÙÃþ
  • Myoelastic layer
    ±ÙÀ°Åº·ÂÃþ
    [¿¾ ¿ë¾î] ±Ùź·ÂÃþ
  • Pretracheal layer
    ±â°ü¾ÕÃþ
    [¿¾ ¿ë¾î] ±â°üÀü¿±
  • Deep layer
    ±íÀºÃþ
    [¿¾ ¿ë¾î] ½É´ë
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
OV oculovestibular; office visit; osteoid volume; outflow volume; ovalbumin; ovary; overventilation; ov...
Ov ovary
PCO patient complains of; polycystic ovary; predicted cardiac output
PCOS polycystic ovary syndrome
POD peroxidase; place of death; podiatry; polycystic ovary disease; pool of doctors; postoperative day; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PCOD Polycystic Ovary Disease
PCO Polycystic Ovary Syndrome
PCO Polycystic ovary
HVL 6-half-value layer
CCT Combined cortical thickness
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • double layer
    ÀÌÁß Ãþ
  • double layer fluorescent antibody technique
    ÀÌÃþ Çü±¤ Ç×ü¹ý
  • floegel's layer
    ÇÃ·Ú°Ö Ãþ
    ±Ù ¼¶À¯ÀÇ Åõ¸í ¿Ü°ü¿¡ ÀÖ´Â °ú¸³ Ãþ.
  • interface layer
    °è¸éÃþ
  • layer
    Ãþ
    ½×Àº, °ãÄ£, Ä¥ÇÑ, µÎ²².
  • malpighian layer
    malpighi Ãþ
  • mantle layer
    ¿ÜÅõ Ãþ
  • molecular layer
    ºÐÀÚ Ãþ
  • mucous layer
    Á¡¾×Ãþ
  • nerve cell layer
    ½Å°æ ¼¼Æ÷ Ãþ
  • odondoblastic layer
    Á¶»ó¾Æ¼¼Æ÷ Ãþ
  • odontoblastic layer
    Á¶»ó¾Æ¼¼Æ÷Ãþ
  • outer granular layer
    ¿Ü°ú¸³Ãþ
  • papillary layer
    À¯µÎÃþ
    ÁøÇǰ¡ Ç¥ÇǸ¦ ¹Ð°í µé¾î°¡ »ý±ä ÁøÇÇ À¯µÎ¿Í Ç¥Çǰ¡ ÁøÇÇÂÊÀ¸·Î ¹Ð°í ³»·Á¿Í ¸¸µé¾îÁø Ç¥ÇÇ ´É¼± ¶Ç´Â Ç¥ÇÇ ½û±â·Î ±¸¼ºµÇ¾î ÀÖ´Ù.
  • phosphor layer
    ÀÎÃþ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
adrenal cortical carcinomas Large invasive and metastasizing tumours which may cause virilism or Cushing's syndrome.
(05 Mar 2000)
adrenal cortical syndrome <syndrome> An inexact (and obsolete) term that has been applied to Cushing's syndrome, Addison's disease, or the adrenogenital syndrome.
(05 Mar 2000)
blindness, cortical Total loss of vision in all or part of the visual field due to a lesion in the striate area, characterised by the patient's subjective unawareness of his disability and the absence of cortical functions of vision, with the subcortical functions intact.
(12 Dec 1998)
carcinoma, adrenal cortical A malignant neoplasm of adrenal cortical cells demonstrating partial or complete histological and functional differentiation. They are rare, comprising between only 0.05% and 0.2% of all cancers. Women develop functional adrenal cortical carcinomas more commonly than men, but men develop nonfunctioning ones more often than women. Hypercortisolism is the most common presentation for this cancer. Virilism and cushing's syndrome may also result.
(12 Dec 1998)
generalised cortical hyperostosis <syndrome> An inherited skeletal dysplasia, with mandibular enlargement and thickening of the diaphyses and calvaria, and increased serum alkaline phosphatase; autosomal recessive inheritance.
Synonym: generalised cortical hyperostosis.
(05 Mar 2000)
renal cortical adenoma <tumour> One of the usually small adenoma's sometimes found in the renal cortex and derived from renal tubular tissue.
(05 Mar 2000)
renal cortical lobule One of the subdivisions of the kidney, consisting of a medullary ray and that portion of the convoluted port (renal corpuscles and convoluted tubules) associated with its collecting duct.
Synonym: lobulus corticalis renalis, renal cortical lobule, renculus, reniculus, renunculus.
(05 Mar 2000)
metaphysial fibrous cortical defect A small (less than 2 to 3 cm in diameter) fibrous cortical d.
(05 Mar 2000)
cortical <anatomy> Pertaining to or of the nature of a cortex or bark.
Origin: L. Corticalis
(18 Nov 1997)
cortical apraxia An inability to make movements or to use objects for the purpose intended.
Synonym: cortical apraxia, innervation apraxia, limb-kinetic apraxia.
(05 Mar 2000)
cortical arches of kidney The portions of renal substance (cortex) intervening between the bases of the pyramids and the capsule of the kidney.
(05 Mar 2000)
cortical arteries Branches of the anterior, middle, and posterior cerebral artery's that supply the cerebral cortex.
(05 Mar 2000)
cortical audiometry Measurement of the potentials that arise in the auditory system above the level of the brainstem.
(05 Mar 2000)
cortical blindness Loss of sight due to an organic lesion in the visual cortex.
(05 Mar 2000)
cortical bone The superficial thin layer of compact bone.
Synonym: substantia corticalis, cortical substance.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á